Related Experiment Video
Updated: Apr 14, 2026
06:10
Author Spotlight: Advancing Corneal Innervation Research Through Innovative Models
Published on: December 8, 2023
2.9K
Curcumin nanoparticles inhibit corneal neovascularization
Nirparaj Pradhan1, Rajdeep Guha2, Sushovan Chowdhury2
1West Bengal University of Animal and Fishery Sciences, 37 & 68 Kshudiram Bose Sarani, Belgachia, Kolkata, 700037, West Bengal, India.
Journal of Molecular Medicine (Berlin, Germany)
|April 17, 2015
Summary
Curcumin nanoparticles effectively prevent corneal neovascularization by enhancing drug retention and suppressing key inflammatory markers. This novel nanoparticle formulation shows promise as a safe and effective therapy for vision-compromising eye conditions.
Area of Science:
- Ophthalmology
- Nanomedicine
- Biomaterials
Background:
- Corneal neovascularization (CNV) significantly impairs vision and presents a major therapeutic challenge.
- Current treatments for CNV lack efficacy and safety, necessitating novel therapeutic strategies.
- Curcumin, a natural compound, possesses anti-angiogenic properties but suffers from poor bioavailability.
Purpose of the Study:
- To evaluate the efficacy of curcumin nanoparticles (NPs) for the prevention of corneal neovascularization.
- To assess the safety and ocular retention of topical curcumin NPs.
- To elucidate the underlying molecular mechanisms of curcumin NP-mediated CNV prevention.
Main Methods:
- Curcumin-loaded MePEG-PCL nanoparticles were synthesized and characterized.
- In vitro assessment of anti-angiogenic effects on sprouting.
- In vivo topical ocular delivery in a rabbit model of corneal neovascularization.
- Clinical grading, histopathology, and molecular analysis (VEGF, cytokines, MMP, NFκB) were performed.
Main Results:
- Curcumin NPs demonstrated enhanced anti-angiogenic activity in vitro.
- Topical application resulted in superior curcumin retention in the cornea compared to free curcumin.
- Significant reduction in CNV was observed clinically and histopathologically.
- Suppression of VEGF, inflammatory cytokines, MMPs, and NFκB activation was evidenced in treated corneas.
- No adverse effects on corneal structure were noted.
Conclusions:
- Curcumin nanoparticles offer enhanced corneal retention and potent anti-CNV effects.
- The mechanism involves suppression of VEGF, inflammatory pathways, and NFκB signaling.
- Curcumin NPs represent a promising, safe therapeutic candidate for preventing corneal neovascularization.
